Kolon Investment

Neurophet, Inc. is a neuroscience company based in Seoul, South Korea, founded in 2016. It specializes in developing innovative software solutions for brain stimulation and treatment of neurological disorders. The company's flagship product, Neurophet tES Lab, is a simulation software that calculates and visualizes the effects of brain stimulation by utilizing individual brain structures and specific stimulation conditions. Neurophet employs its proprietary Segengine technology, which can automatically segment brain magnetic resonance images into 107 distinct regions within a minute. This technology aids in predicting and investigating stimulation effects for conditions such as Alzheimer's disease, providing clinicians with a three-dimensional brain model and stimulation parameter guidance. By leveraging deep learning and numerical optimization techniques, Neurophet enables healthcare professionals to focus interventions on targeted regions of the brain, enhancing treatment efficacy for patients with brain diseases.

My Franchise is a company founded in 2019 in Seoul, South Korea, that addresses the information gap between franchise headquarters and potential founders. It operates an online platform that facilitates connections between these two parties, optimizing their partnership potential. The platform offers valuable insights for prospective founders, including data on the number of franchisees by year, average sales figures, and start-up costs associated with domestic franchise brands. This allows users to effectively compare and analyze important brand information across various industries, enabling informed decision-making for franchise investments.

Uneedcomms, Inc. is a South Korean company specializing in data-driven e-commerce and marketing solutions. Founded in 2014, the company offers innovative products such as SMARTSKIN, a mobile shopping solution, and TARGETBOOK, a big data-based advertising management tool. TARGETBOOK analyzes shopping mall user behavior to optimize ad targeting and synchronizes product information in real time, facilitating effective advertising for mall retailers. Additionally, it automates the creation and editing of promotional content, allowing businesses to focus on strategic decision-making rather than repetitive tasks. Uneedcomms aims to enhance the efficiency of small and medium-sized e-commerce businesses, positioning itself as a key player in the evolving digital marketplace.

Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a unique bispecific antibody platform technology known as AliCE, which retains the structure of the parental antibody to ensure high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL library, which comprises a diverse range of antibodies. The company also offers contract research services, further contributing to its position in the antibody drug market. Through its innovative technologies and research efforts, Y-Biologics aims to advance its portfolio of antibody drugs and strengthen its role in the global immuno-chemotherapeutic landscape.

Cyrus Therapeutics is a biotechnology company based in Seoul, South Korea, focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases, particularly those related to metabolic conditions, obesity, and refractory issues. Founded in 2019, the company utilizes various drug modalities, including traditional small molecule inhibitors and targeted protein degraders, to create medicines for patients with high unmet medical needs. Through its advanced technology, Cyrus Therapeutics aims to develop effective treatments for conditions that are often considered undruggable.

Neurophet, Inc. is a neuroscience company based in Seoul, South Korea, founded in 2016. It specializes in developing innovative software solutions for brain stimulation and treatment of neurological disorders. The company's flagship product, Neurophet tES Lab, is a simulation software that calculates and visualizes the effects of brain stimulation by utilizing individual brain structures and specific stimulation conditions. Neurophet employs its proprietary Segengine technology, which can automatically segment brain magnetic resonance images into 107 distinct regions within a minute. This technology aids in predicting and investigating stimulation effects for conditions such as Alzheimer's disease, providing clinicians with a three-dimensional brain model and stimulation parameter guidance. By leveraging deep learning and numerical optimization techniques, Neurophet enables healthcare professionals to focus interventions on targeted regions of the brain, enhancing treatment efficacy for patients with brain diseases.

Cyrus Therapeutics is a biotechnology company based in Seoul, South Korea, focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases, particularly those related to metabolic conditions, obesity, and refractory issues. Founded in 2019, the company utilizes various drug modalities, including traditional small molecule inhibitors and targeted protein degraders, to create medicines for patients with high unmet medical needs. Through its advanced technology, Cyrus Therapeutics aims to develop effective treatments for conditions that are often considered undruggable.

THE PIRATES is a platform that offers national fish market price and seafood.

Spendit is a B2B fintech company in Seoul, Korea.

Neurophet, Inc. is a neuroscience company based in Seoul, South Korea, founded in 2016. It specializes in developing innovative software solutions for brain stimulation and treatment of neurological disorders. The company's flagship product, Neurophet tES Lab, is a simulation software that calculates and visualizes the effects of brain stimulation by utilizing individual brain structures and specific stimulation conditions. Neurophet employs its proprietary Segengine technology, which can automatically segment brain magnetic resonance images into 107 distinct regions within a minute. This technology aids in predicting and investigating stimulation effects for conditions such as Alzheimer's disease, providing clinicians with a three-dimensional brain model and stimulation parameter guidance. By leveraging deep learning and numerical optimization techniques, Neurophet enables healthcare professionals to focus interventions on targeted regions of the brain, enhancing treatment efficacy for patients with brain diseases.

Dunamu Inc. is a South Korean company founded in 2012 that specializes in blockchain and securities services. It operates UPbit, a prominent global cryptocurrency exchange, as well as Stockplus, a securities information and trading platform, and U-Stockplus, an over-the-counter platform for private company trading. Additionally, Dunamu offers Luniverse, a blockchain-as-a-service solution, and Onboard, an equity management platform designed for private companies to manage shareholder equity electronically. The company's services are accessible through a mobile application, which provides users with real-time cryptocurrency prices and analytics, ensuring a secure and user-friendly trading experience across various markets.

Eutilex Co., Ltd. is a biotechnology company based in South Korea that specializes in the development of immunotherapy technologies aimed at treating tumors. The company focuses on anti-tumor T cell therapy and antibody therapeutics, creating innovative treatments to combat cancer. Eutilex's product pipeline includes advanced therapies such as T Cell Therapy (4-1BB CTL), CAR-T, and various antibody-based treatments. The company markets its offerings throughout South Korea, contributing to the growing field of cancer immunotherapy.

Newploy is a South Korean company, established in 2014, that specializes in developing a payroll work automation platform. The software utilizes robotic process automation (RPA) technology to streamline payroll tasks, including salary calculation, transfer, reporting, and payment. Additionally, it offers workforce management solutions that help businesses track employee work hours and manage various payroll-related functions. Newploy's platform centralizes crucial aspects of staffing needs, such as leave management, attendance tracking, and work scheduling, thereby enhancing operational efficiency for organizations.

AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, that specializes in the discovery and development of selective inhibitors targeting the NOX family of enzymes, as well as aptamer-based anti-cancer drugs. The company's product offerings include a range of transfection reagents designed for DNA or RNA delivery into eukaryotic cells. AptaBio is advancing several product candidates aimed at addressing significant health issues, including PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 for non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics focuses on creating innovative solutions for complex medical challenges.

C-TRI is involved in the manufacturing and advancement of pharmaceutical products. C-Tri Co., Ltd., based in Namyangju, South Korea, specializes in the production and development of pharmaceutical products. They offer a wide range of products, including peptides, antiviral drugs, ionic liquids, and more. Additionally, C-Tri Co., Ltd. provides OTC and ETC contract services. The company was established in 1998.

SeeOn (씨온) is a Korean location-based social network service that allows users to contact other users and share experiences with one another. Established in 2012, SeeOn was awarded the social networking app of the year in 2012 in the LBS smart app awards.